Infliximab (Remicade) in the treatment of psoriatic arthritis

References

• Abu-ShakraMGladmanDDThorneJCLongterm methotrexate therapy in psoriatic arthritis: clinical and radiological outcomeJ Rheumatol19952224157738945
   PubMed Web of Science ®Google Scholar
• AntoniCDechantCHanns-Martin LorenzPDOpen-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammationArthritis Rheum2002475061212382299
   PubMed Web of Science ®Google Scholar
• AntoniCKruegerGGde VlamKInfliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trialAnn Rheum Dis2005641150715677701
   PubMed Web of Science ®Google Scholar
• AntoniCEKavanaughAKirkhamBSustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Arthritis Rheum20055212273615818699
   PubMed Web of Science ®Google Scholar
• ArmstrongRDPanayiGSWelshKIHistocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitisAnn Rheum Dis19834214266573872
   PubMed Web of Science ®Google Scholar
• AsklingJForedCMBaecklundEHaematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonistsAnn Rheum Dis20056414142015843454
   PubMed Web of Science ®Google Scholar
• AsklingJForedCMBrandtLRisks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonistsAnn Rheum Dis2005641421615829572
   PubMed Web of Science ®Google Scholar
• BertoliniDRNedwinGEBringmanTSStimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factorsNature1986319516183511389
   PubMed Web of Science ®Google Scholar
• BlumbergBSBunimJJCalkinsEARA nomenclature and classification of arthritis and rheumatismArthritis Rheum1964793714118668
   PubMed Web of Science ®Google Scholar
• BowcockAMUnderstanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunologyImmunol Res200532455616106058
   PubMed Web of Science ®Google Scholar
• BowcockAMCooksonWOThe genetics of psoriasis, psoriatic arthritis and atopic dermatitisHum Mol Genet200413R435514996755
   PubMed Web of Science ®Google Scholar
• BraunJSieperJRole of novel biological therapies in psoriatic arthritis: effects on joints and skinBioDrugs2003171879912749755
   PubMed Web of Science ®Google Scholar
• BrockbankJGladmanDDiagnosis and management of psoriatic arthritisDrugs20026224475712421102
   PubMed Web of Science ®Google Scholar
• BurgessTLQianYKaufmanSThe ligand for osteoprotegerin (OPGL) directly activates mature osteoclastsJ Cell Biol19991455273810225954
   PubMed Web of Science ®Google Scholar
• CheifetzASmedleyMMartinSThe incidence and management of infusion reactions to infliximab: a large center experienceAm J Gastroenterol20039813152412818276
   PubMed Web of Science ®Google Scholar
• CostelloPBresnihanBO’FarrellyCPredominance of CD8+ T lymphocytes in psoriatic arthritisJ Rheumatol19992611172410332977
   PubMed Web of Science ®Google Scholar
• DayerJMBeutlerBCeramiACachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblastsJ Exp Med1985162216382999289
   PubMed Web of Science ®Google Scholar
• DelaunayCFarrenqVMarini-PortugalAInfliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary dataJ Rheumatol2005322183516265699
   PubMed Web of Science ®Google Scholar
• EastmondCJWrightVThe nail dystrophy of psoriatic arthritisAnn Rheum Dis1979382268485578
   PubMed Web of Science ®Google Scholar
• EllisCNKruegerGGTreatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytesN Engl J Med20013452485511474662
   PubMed Web of Science ®Google Scholar
• EspinozaLRAguilarJLEspinozaCGFibroblast function in psoriatic arthritis. I. Alteration of cell kinetics and growth factor responsesJ Rheumatol199421150267983654
   PubMed Web of Science ®Google Scholar
• EspinozaLRCuellarMLSilveiraLHPsoriatic arthritisCurr Opin Rheumatol1992447081503870
   PubMedGoogle Scholar
• EspinozaLREspinozaCGCuellarMLFibroblast function in psoriatic arthritis. II. Increased expression of beta platelet derived growth factor receptors and increased production of growth factor and cytokinesJ Rheumatol1994211507117983655
   PubMed Web of Science ®Google Scholar
• FournieBCrognierLArnaudCProposed classification criteria of psoriatic arthritis. A preliminary study in 260 patientsRev Rhum Engl Ed1999664465610567972
   PubMedGoogle Scholar
• GelfandJMGladmanDDMeasePJEpidemiology of psoriatic arthritis in the population of the United StatesJ Am Acad Dermatol20055357316198775
   PubMed Web of Science ®Google Scholar
• GiustizieriMLMasciaFFrezzoliniAKeratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokinesJ Allergy Clin Immunol2001107871711344355
   PubMed Web of Science ®Google Scholar
• GladmanDDToward unraveling the mystery of psoriatic arthritisArthritis Rheum19933688148318035
   PubMedGoogle Scholar
• GladmanDDPsoriatic arthritisRheum Dis Clin North Am19982482944x9891713
   PubMed Web of Science ®Google Scholar
• GladmanDDEffectiveness of psoriatic arthritis therapiesSemin Arthritis Rheum200333293712920694
   PubMed Web of Science ®Google Scholar
• GladmanDDTraditional and newer therapeutic options for psoriatic arthritis: an evidence-based reviewDrugs20056512233815916449
   PubMed Web of Science ®Google Scholar
• GladmanDDAnhornKASchachterRKHLA antigens in psoriatic arthritisJ Rheumatol198613586923735281
   PubMed Web of Science ®Google Scholar
• GladmanDDAntoniCMeasePPsoriatic arthritis: epidemiology, clinical features, course, and outcomeAnn Rheum Dis200564Suppl 2ii14715708927
   PubMed Web of Science ®Google Scholar
• GladmanDDCheungCNgCMHLA-C locus alleles in patients with psoriatic arthritis (PsA)Hum Immunol1999602596110321964
   PubMed Web of Science ®Google Scholar
• GladmanDDFarewellVTKopciukKAHLA markers and progression in psoriatic arthritisJ Rheumatol19982573039558177
   PubMed Web of Science ®Google Scholar
• GladmanDDFarewellVTPellettFHLA is a candidate region for psoriatic arthritis. evidence for excessive HLA sharing in sibling pairsHum Immunol200364887912941544
   PubMed Web of Science ®Google Scholar
• GladmanDDShuckettRRussellMLPsoriatic arthritis (PSA)—an analysis of 220 patientsQ J Med198762127413659255
   PubMedGoogle Scholar
• Gomez-ReinoJJCarmonaLSwitching TNF antagonists in patients with chronic arthritis: an observational study of 488 patients over a four-year periodArthritis Res Ther20068R2916507128
   PubMed Web of Science ®Google Scholar
• GordonKBPappKAHamiltonTKEfalizumab for patients with moderate to severe plaque psoriasis: a randomized controlled trialJAMA200329030738014679270
   PubMed Web of Science ®Google Scholar
• GottliebABEvansRLiSInfliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trialJ Am Acad Dermatol2004515344215389187
   PubMed Web of Science ®Google Scholar
• HelliwellPSTaylorWJClassification and diagnostic criteria for psoriatic arthritisAnn Rheum Dis200564Suppl 2ii3815708931
   PubMed Web of Science ®Google Scholar
• HustedJAGladmanDDFarewellVTHealth-related quality of life of patients with psoriatic arthritis: a comparison with patients with rheumatoid arthritisArthritis Rheum200145151811324779
   PubMed Web of Science ®Google Scholar
• KarasonAGudjonssonJEUpmanyuRA susceptibility gene for psoriatic arthritis maps to chromosome 16q: evidence for imprintingAm J Hum Genet2003721253112474146
   PubMed Web of Science ®Google Scholar
• KavanaughAAntoniCKruegerGGInfliximab improves health related quality of life and physical function in patients with psoriatic arthritisAnn Rheum Dis200665471716096330
   PubMed Web of Science ®Google Scholar
• KavanaughAAntoniCEGladmanDDThe Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): Results of radiographic analyses after 1 yearAnn Rheum Dis20066510384316439444
   PubMed Web of Science ®Google Scholar
• KeystoneECKavanaughAFSharpJTRadiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trialArthritis Rheum20045014001115146409
   PubMed Web of Science ®Google Scholar
• KormanNJMoulDKAlefacept for the treatment of psoriasis: a review of the current literature and practical suggestions for everyday clinical useSemin Cutan Med Surg20052410815900794
   PubMed Web of Science ®Google Scholar
• LaceyDLTimmsETanHLOsteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activationCell199893165769568710
   PubMed Web of Science ®Google Scholar
• LangevitzPBuskilaDGladmanDDPsoriatic arthritis precipitated by physical traumaJ Rheumatol19901769572359083
   PubMed Web of Science ®Google Scholar
• LebwohlMTingPTKooJYPsoriasis treatment: traditional therapyAnn Rheum Dis200564Suppl 2ii83615708945
   PubMedGoogle Scholar
• LebwohlMTyringSKHamiltonTKA novel targeted T-cell modulator, efalizumab, for plaque psoriasisN Engl J Med200334920041314627785
   PubMed Web of Science ®Google Scholar
• LeonardDGO’DuffyJDRogersRSProspective analysis of psoriatic arthritis in patients hospitalized for psoriasisMayo Clin Proc19785351118682678
   PubMed Web of Science ®Google Scholar
• MaderRGladmanDDLongJDoes injectable gold retard radiologic evidence of joint damage in psoriatic arthritis?Clin Invest Med199518139437788959
   PubMed Web of Science ®Google Scholar
• MarguerieLFlipoRMGrardelBUse of disease-modifying antirheumatic drugs in patients with psoriatic arthritisJoint Bone Spine2002692758112102274
   PubMed Web of Science ®Google Scholar
• MeasePSmolenJSPsoriatic arthritis/psoriasisTargeted Therapies in Rheumatology2003LondonMartin Dunitz Ltd52548
   Google Scholar
• MeasePEfalizumab in psoriatic arthritis2004aToronto, CanadaInternational Psoriasis Society
   Google Scholar
• MeasePTNFalpha therapy in psoriatic arthritis and psoriasisAnn Rheum Dis2004b63755815194567
   PubMed Web of Science ®Google Scholar
• MeasePGladmanDKeystoneEEfficacy of alefacept in combination with methotrexate in the treatment of psoriatic arthritisAnn Rheum Dis200564324
   Web of Science ®Google Scholar
• MeasePGoffeBSDiagnosis and treatment of psoriatic arthritisJ Am Acad Dermatol20055211915627075
   PubMed Web of Science ®Google Scholar
• MeasePJAntoniCEPsoriatic arthritis treatment: biological response modifiersAnn Rheum Dis200564Suppl 2ii788215708944
   PubMedGoogle Scholar
• MeasePJGladmanDDKeystoneECAlefacept in combination with methotrexate for the treatment of psoriatic arthritis: results of a randomized, double-blind, placebo-controlled studyArthritis Rheum20065416384516646026
   PubMed Web of Science ®Google Scholar
• MeasePJGladmanDDRitchlinCTAdalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trialArthritis Rheum20055232798916200601
   PubMed Web of Science ®Google Scholar
• MeasePJGoffeBSMetzJEtanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialLancet20003563859010972371
   PubMed Web of Science ®Google Scholar
• MeasePJKivitzAJBurchFXEtanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progressionArthritis Rheum20045022647215248226
   PubMed Web of Science ®Google Scholar
• MollJMWrightVFamilial occurrence of psoriatic arthritisAnn Rheum Dis1973a321812014715537
   PubMed Web of Science ®Google Scholar
• MollJMWrightVPsoriatic arthritisSemin Arthritis Rheum1973b355784581554
   PubMedGoogle Scholar
• NakashimaTWadaTPenningerJMRANKL and RANK as novel therapeutic targets for arthritisCurr Opin Rheumatol200315280712707582
   PubMed Web of Science ®Google Scholar
• NashPCleggDOPsoriatic arthritis therapy: NSAIDs and traditional DMARDsAnn Rheum Dis200564Suppl 2ii74715708943
   PubMedGoogle Scholar
• OryPARadiography in the assessment of musculoskeletal conditionsBest Pract Res Clin Rheumatol20031749551212787514
   PubMed Web of Science ®Google Scholar
• OryPAGladmanDDMeasePJPsoriatic arthritis and imagingAnn Rheum Dis200564Suppl 2ii55715708938
   PubMed Web of Science ®Google Scholar
• PipitoneNKingsleyGHManzoACurrent concepts and new developments in the treatment of psoriatic arthritisRheumatology (Oxford)20034211384812810935
   PubMed Web of Science ®Google Scholar
• RahmanPBartlettSSiannisFCARD15: a pleiotropic autoimmune gene that confers susceptibility to psoriatic arthritisAm J Hum Genet2003736778112879366
   PubMed Web of Science ®Google Scholar
• RahmanPGladmanDDCookRJThe use of sulfasalazine in psoriatic arthritis: a clinic experienceJ Rheumatol1998251957619779850
   PubMed Web of Science ®Google Scholar
• ReichKNestleFOPappKInfliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trialLancet200536613677416226614
   PubMed Web of Science ®Google Scholar
• ReichKNestleFOPappKImprovement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trialBr J Dermatol20061541161816704649
   PubMed Web of Science ®Google Scholar
• RemicadeRemicade package insert, EU2006aMalvern, PACentocor, Inc.
   Google Scholar
• RemicadeRemicade package insert, US2006bMalvern, PACentocor, Inc.
   Google Scholar
• RitchlinCAnandarajahaATottermanSPreliminary data from a study of adalimumab in the treatment of psoriatic arthritis [abstract]Ann Rheum Dis200463403
   Web of Science ®Google Scholar
• RitchlinCHaas-SmithSAHicksDPatterns of cytokine production in psoriatic synoviumJ Rheumatol1998251544529712099
   PubMed Web of Science ®Google Scholar
• RitchlinCTHaas-SmithSALiPMechanisms of TNF-alpha-and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritisJ Clin Invest20031118213112639988
   PubMed Web of Science ®Google Scholar
• SaklatvalaJTumour necrosis factor alpha stimulates resorption and inhibits synthesis of proteoglycan in cartilageNature198632254793736671
   PubMed Web of Science ®Google Scholar
• SalonenSThe EUROPSO psoriasis patient study: treatment history and satisfaction reported by 17,900 members of European psoriasis patients associations (poster).2003
   Google Scholar
• ShbeebMUramotoKMGibsonLEThe epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982–1991J Rheumatol20002712475010813295
   PubMed Web of Science ®Google Scholar
• SoderlinMKBorjessonOKautiainenHAnnual incidence of inflammatory joint diseases in a population based study in southern SwedenAnn Rheum Dis2002619111512228162
   PubMed Web of Science ®Google Scholar
• SokollKBHelliwellPSComparison of disability and quality of life in rheumatoid and psoriatic arthritisJ Rheumatol2001281842611508587
   PubMed Web of Science ®Google Scholar
• SwanbeckGInerotAMartinssonTGenetic counselling in psoriasis: empirical data on psoriasis among first-degree relatives of 3095 psoriatic probandsBr J Dermatol1997137939429470911
   PubMed Web of Science ®Google Scholar
• TaylorWClASsification criteria for Psoriatic ARthritis: results from the CASPAR studyArthritis Rheum20065426657316871531
   PubMed Web of Science ®Google Scholar
• TerajimaSHigakiMIgarashiYAn important role of tumor necrosis factor-alpha in the induction of adhesion molecules in psoriasisArch Dermatol Res1998290246529681675
   PubMed Web of Science ®Google Scholar
• Van den BoschFKruithofEBaetenDEffects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot studyAnn Rheum Dis2000594283310834859
   PubMed Web of Science ®Google Scholar
• Van der HeijdeDGladmanDKavanaughAInfliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis: 54 week results from IMPACT 2Arthritis Rheum200552S281
   Google Scholar
• VealeDRogersSFitzgeraldOImmunolocalization of adhesion molecules in psoriatic arthritis, psoriatic and normal skinBr J Dermatol19951323287538776
   PubMed Web of Science ®Google Scholar
• VealeDYanniGRogersSReduced synovial membrane macrophage numbers, ELAM-1 expression, and lining layer hyperplasia in psoriatic arthritis as compared with rheumatoid arthritisArthritis Rheum1993368939007686370
   PubMed Web of Science ®Google Scholar
• VealeDJRitchlinCFitzGeraldOImmunopathology of psoriasis and psoriatic arthritisAnn Rheum Dis200564Suppl 2ii26915708930
   PubMed Web of Science ®Google Scholar
• WassenbergSFischer-KahleVHerbornGA method to score radiographic change in psoriatic arthritisZ Rheumatol2001601566611475603
   PubMed Web of Science ®Google Scholar
• WickMCErnestamSLindbladSAdalimumab (Humira) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade) or etanercept (Enbrel): results from the STURE registry at Karolinska University HospitalScand J Rheumatol200534353816234182
   PubMed Web of Science ®Google Scholar
• WongKGladmanDDHustedJMortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of deathArthritis Rheum1997401868729336423
   PubMed Web of Science ®Google Scholar
• WrightVRheumatism and psoriasis: a re-evaluationAm J Med1959274546213846114
   PubMed Web of Science ®Google Scholar
• ZachariaeHPrevalence of joint disease in patients with psoriasis: implications for therapyAm J Clin Dermatol20034441712814334
   PubMed Web of Science ®Google Scholar